Materia Licenses Technology To Merck

Pasadena-based Materia, a provider of catalysts for pharmaceutical products, said today that it has licensed its metathesis platform to pharmaceutical company Merck & Co. Financial terms of the non-exclusive license were not disclosed. Materia's technology is used for synthesizing new pharmaceutical products and for production processes. Materia said the technology will be used by Merck in its drug discovery and development programs.